Knowledge Hub

Vaccinating pregnant women against pertussis greatly reduces the risk of the disease in infants and infant deaths

Vaccinating pregnant women against pertussis at least one week before delivery was found to be 91% effective in preventing the disease in infants <3 months old and 95% effective in preventing infant deaths in a study conducted in England over a 3-year period following the introduction of dTap-IPV vaccine for pregnant women. Of the 37 deaths from pertussis in infants that occurred in England from 2009 to 2015, 32 (86%) were in infants <2 months of age, highlighting the vulnerability of very young infants to severe pertussis. All but 2 of the deaths in <2 month olds were in children whose mothers hadn’t been vaccinated against pertussis during their pregnancy, while in the 2 other cases, the vaccination occurred too late in the pregnancy (<10 days before the birth).

Full Citation:
Amirthalingam G, Campbell H, Ribeiro S et al.. 2016. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clinical Infectious Diseases. 63 (Suppl 4).

Title of Article: Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction

Author(s): Amirthalingam G, Campbell H, Ribeiro S et al.

Publication Year: 2016

Publication Name: Clinical Infectious Diseases

Publication Volume: 63 (Suppl 4)

Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/27838678/

DOI (Digital Object Identifier): 10.1093/cid/ciw559

Topics: Health

Disease Vaccines: Pertussis

Countries: England

WHO Regions: Europe